These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 32967763)
1. [miR-93-5p promotes invasion and migration of triple negative breast cancer cells by targeting FGD5]. Zhou D; Bai J; Hu Y; Zhang L; Zheng Q; Zhong W; Mu Q; Li H; Lyu S; Yin C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):794-801. PubMed ID: 32967763 [TBL] [Abstract][Full Text] [Related]
2. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392 [TBL] [Abstract][Full Text] [Related]
3. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p. Aichen Z; Kun W; Xiaochun S; Lingling T Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. Chen LL; Zhang ZJ; Yi ZB; Li JJ Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042 [TBL] [Abstract][Full Text] [Related]
7. The Antimicrobial Peptide Merecidin Inhibit the Metastasis of Triple-Negative Breast Cancer by Obstructing EMT via miR-30d-5p/Vimentin. Ma F; Song J; He M; Wang X Technol Cancer Res Treat; 2024; 23():15330338241281310. PubMed ID: 39267432 [No Abstract] [Full Text] [Related]
8. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients. Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197 [TBL] [Abstract][Full Text] [Related]
9. Unleashing Breast Cancer Progression: miR-455-5p's Targeting of SOCS3 Drives Proliferation, Migration, and Invasion. Li X; Peng B; Li J; Tian M; He L Protein Pept Lett; 2023; 30(12):992-1000. PubMed ID: 38013437 [TBL] [Abstract][Full Text] [Related]
10. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis. Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241 [TBL] [Abstract][Full Text] [Related]
11. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related]
12. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway. Liu G; Wang P; Zhang H J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779 [TBL] [Abstract][Full Text] [Related]
13. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2. Wang LB; Feng L; He J; Liu B; Sun JG Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596 [No Abstract] [Full Text] [Related]
14. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Han C; Fu Y; Zeng N; Yin J; Li Q Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085 [TBL] [Abstract][Full Text] [Related]
15. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling. Wang Z; Wang X J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468 [TBL] [Abstract][Full Text] [Related]
16. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1. Wang X; Zhou X; Zeng F; Wu X; Li H Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736 [TBL] [Abstract][Full Text] [Related]
17. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. Liu F; Zhuang L; Wu R; Li D J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854 [TBL] [Abstract][Full Text] [Related]
18. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
19. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer. Ma S; Wei H; Wang C; Han J; Chen X; Li Y Cell Mol Biol Lett; 2021 Dec; 26(1):52. PubMed ID: 34895159 [TBL] [Abstract][Full Text] [Related]
20. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2. Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]